IMNM
Immunome Inc

2,058
Mkt Cap
$1.75B
Volume
1.01M
52W High
$20.46
52W Low
$5.15
PE Ratio
-6.87
IMNM Fundamentals
Price
$20.30
Prev Close
$19.06
Open
$19.10
50D MA
$16.50
Beta
1.24
Avg. Volume
1.43M
EPS (Annual)
-$5.00
P/B
7.05
Rev/Employee
$76,618.64
Loading...
Loading...
News
all
press releases
Immunome, Inc. (NASDAQ:IMNM) Given Average Rating of "Moderate Buy" by Brokerages
Immunome, Inc. (NASDAQ:IMNM - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the eleven research firms that are presently covering the firm, Marketbeat.com...
MarketBeat·31m ago
News Placeholder
More News
News Placeholder
Kennedy Capital Management LLC Purchases 94,627 Shares of Immunome, Inc. $IMNM
Kennedy Capital Management LLC grew its position in Immunome, Inc. (NASDAQ:IMNM - Free Report) by 642.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and...
MarketBeat·3d ago
News Placeholder
Kennedy Capital Management LLC Purchases 94,627 Shares of Immunome, Inc. $IMNM
Kennedy Capital Management LLC grew its position in Immunome, Inc. (NASDAQ:IMNM - Free Report) by 642.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and...
MarketBeat·3d ago
News Placeholder
Tema Etfs LLC Takes $1.07 Million Position in Immunome, Inc. $IMNM
Tema Etfs LLC acquired a new position in shares of Immunome, Inc. (NASDAQ:IMNM - Free Report) in the 2nd quarter, according to its most recent disclosure with the SEC. The fund acquired 115,431...
MarketBeat·5d ago
News Placeholder
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Immunome, Inc. (the company) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on December 1, 2025, the...
Business Wire·7d ago
News Placeholder
Immunome (NASDAQ:IMNM) Stock Price Up 9.5% - Time to Buy?
Immunome (NASDAQ:IMNM) Stock Price Up 9.5% - Still a Buy...
MarketBeat·7d ago
News Placeholder
Truist Financial Initiates Coverage on Immunome (NASDAQ:IMNM)
Truist Financial started coverage on Immunome in a research report on Monday. They issued a "buy" rating and a $36.00 target price on the stock...
MarketBeat·9d ago
News Placeholder
Immunome (NASDAQ:IMNM) Sets New 12-Month High - Here's Why
Immunome (NASDAQ:IMNM) Hits New 52-Week High - Time to Buy...
MarketBeat·15d ago
News Placeholder
Immunome, Inc. $IMNM Shares Sold by Primecap Management Co. CA
Primecap Management Co. CA reduced its stake in shares of Immunome, Inc. (NASDAQ:IMNM - Free Report) by 11.5% in the 2nd quarter, according to the company in its most recent disclosure with the...
MarketBeat·19d ago
News Placeholder
Immunome (NASDAQ:IMNM) Upgraded at Wall Street Zen
Wall Street Zen upgraded Immunome from a "sell" rating to a "hold" rating in a research note on Saturday...
MarketBeat·19d ago

Latest IMNM News

View

Advertisement|Remove ads.

Advertisement|Remove ads.